text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation Home National Science Foundation - Biological Sciences (BIO)
 
Integrative Organismal Systems (IOS)
design element
IOS Home
About IOS
Funding Opportunities
Awards
News
Events
Discoveries
Publications
Career Opportunities
Examples of Broader Impacts
Supplements & Other Opportunities
See Additional IOS Resources
View IOS Staff
BIO Organizations
Biological Infrastructure (DBI)
Environmental Biology (DEB)
Emerging Frontiers (EF)
Integrative Organismal Systems (IOS)
Molecular and Cellular Biosciences (MCB)
Proposals and Awards
Proposal and Award Policies and Procedures Guide
  Introduction
Proposal Preparation and Submission
bullet Grant Proposal Guide
  bullet Grants.gov Application Guide
Award and Administration
bullet Award and Administration Guide
Award Conditions
Other Types of Proposals
Merit Review
NSF Outreach
Policy Office
Additional IOS Resources
BIO Reports
BIO Dear Colleague Letters
Merit Review
Merit Review Broader Impacts Criterion: Representative Activities
Image Credits
Other Site Features
Special Reports
Research Overviews
Multimedia Gallery
Classroom Resources
NSF-Wide Investments


Press Release 09-071
Shedding Some Light on Parkinson's Treatment

Scientists use optical approach to study deep brain stimulation

Illustration of optogenetic approach used to study Parkinson's treatment.

Optogenetics helps identify cellular targets of deep brain stimulation.
Credit and Larger Version

April 16, 2009

A research team lead by Karl Deisseroth in the bioengineering department at Stanford University has developed a technique to systematically characterize disease circuits in the brain. By precisely controlling individual components of the circuit implicated in Parkinson's disease, the team has identified a specific group of cells as direct targets of deep brain stimulation (DBS), a Parkinson's treatment.

Termed optogenetics, the NSF-funded technology uses light-activated proteins, originally isolated from bacteria, in combination with genetic approaches to control specific parts of the brain. The technique is a vast improvement over previous methods because it allows researchers to precisely stimulate neurons and measure the effect of treatment simultaneously in animals with Parkinson's-like symptoms.

Published in the April 17 issue of Science, Deisseroth's team found they could reduce disease symptoms by preferentially activating neurons that link to the subthalamic nucleus region of the brain. First, these specific cells were treated in a way that made them sensitive to stimulation by blue light, then the team implanted an optical fiber in the brain.

When researchers rapidly flashed blue light inside the animals' brains the disease symptoms improved. In contrast, treating with slower flashes of light actually made the symptoms worse, and targeting other kinds of cells had no effect at all, indicating both proper cell type and stimulation frequency are crucial components of effective treatment. Flashing blue light on portions of the same neurons found closer to the outer surface of the brain had an effect similar to treatment deep within the brain, raising the possibility that researchers may be able to develop treatments that are less invasive than current options.

Approved as a medical treatment in 1997, DBS remains controversial because it doesn't work on all patients. Used to treat Parkinson's disease, depression and movement disorders, DBS involves surgical implantation of a brain pacemaker, which sends electrical impulses into the brain. In the past, researchers have been unable to understand the effective mechanism of DBS because the electrical signal emitted by DBS devices interferes with the ability to observe brain activity.

Explains Deisseroth, "The brain is an electrical device, but it is a very complicated device. Think of it as an orchestra without sections: all of the types of instruments, or cells, are mixed together. Treatments like DBS are unrefined, in that they stimulate all of the cells or instruments. The optogenetic approach allows us to control stimulation of specific cells in the brain on the appropriate timescale, much like a conductor directing specific sections of an orchestra at the appropriate time."

Production of new therapies is always a long-term goal, but for now Deisseroth and his group are focused on mapping disease circuits and understanding brain function. "We need to understand the players before we can develop effective treatment strategies," he stated.

-NSF-

Media Contacts
Lisa Van Pay, NSF (703) 292-8796 lvanpay@nsf.gov
Lily Whiteman, NSF (703) 292-8070 lwhitema@nsf.gov

Principal Investigators
Karl Deisseroth, Stanford University (650) 736-4325 deissero@stanford.edu

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2009, its budget is $9.5 billion, which includes $3.0 billion provided through the American Recovery and Reinvestment Act. NSF funds reach all 50 states through grants to over 1,900 universities and institutions. Each year, NSF receives about 44,400 competitive requests for funding, and makes over 11,500 new funding awards. NSF also awards over $400 million in professional and service contracts yearly.

 Get News Updates by Email 

Useful NSF Web Sites:
NSF Home Page: http://www.nsf.gov
NSF News: http://www.nsf.gov/news/
For the News Media: http://www.nsf.gov/news/newsroom.jsp
Science and Engineering Statistics: http://www.nsf.gov/statistics/
Awards Searches: http://www.nsf.gov/awardsearch/

 

Illustration showing how light-activated proteins and fiberoptics helps Parkinsonian animals.
Use of light-activated proteins and fiberoptics helps Parkinsonian animals move more easily.
Credit and Larger Version

April 17, 2009, cover of Science magazine.
The researchers' findings are published in the April 17, 2009, issue of Science magazine.
Credit and Larger Version



Print this page
Back to Top of page
  Web Policies and Important Links | Privacy | FOIA | Help | Contact NSF | Contact Webmaster | SiteMap  
National Science Foundation Biological Sciences (BIO)
The National Science Foundation, 4201 Wilson Boulevard, Arlington, Virginia 22230, USA
Tel:  (703) 292-5111, FIRS: (800) 877-8339 | TDD: (800) 281-8749
Last Updated:
April 16, 2009
Text Only


Last Updated: April 16, 2009